Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001013594-15-000035
Filing Date
2015-01-28
Accepted
2015-01-28 17:01:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 JANUARY 28, 2015 fennec13ga-021415.htm SC 13G/A 116552
  Complete submission text file 0001013594-15-000035.txt   118341
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Subject) CIK: 0001211583 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-80470 | Film No.: 15555575
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 3 COLUMBUS CIRCLE SUITE 2205 NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE SUITE 2205 NEW YORK NY 10019 212-554-2390
683 Capital Management, LLC (Filed by) CIK: 0001404574 (see all company filings)

EIN.: 205100992 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A